NCT04400708

Brief Summary

This study evaluates the effect of the single-injection adductor canal block in patients receiving total knee arthroplasty under spinal anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 22, 2020

Completed
6 days until next milestone

Study Start

First participant enrolled

May 28, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 22, 2021

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 29, 2021

Completed
Last Updated

November 24, 2023

Status Verified

November 1, 2023

Enrollment Period

1.1 years

First QC Date

May 19, 2020

Last Update Submit

November 21, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • the sum of pain score

    VAS pain score (0 to 10) is measured using numeric pain rating scale at 2 hours, 6 hours, 12 hours, and 24 hours 0: no pain, 10: worst pain

    2 hours, 6 hours, 12 hours, and 24 hours after intervention

Secondary Outcomes (2)

  • Postoperative nausea and vomiting

    2 hours, 6 hours, 12 hours, and 24 hours after intervention

  • Postoperative opioid consumption

    2 hours, 6 hours, 12 hours, and 24 hours intervention

Study Arms (2)

control group

SHAM COMPARATOR

normal saline injection

Procedure: control group

test group

EXPERIMENTAL

0.5% ropivacaine injection

Procedure: adductor canal block

Interventions

After the end of the surgery, at the arrival of PACU, the patient's leg is prepared and draped in a sterile manner. Assisted by the high-frequency linear ultrasound transducer, we target the mid-thigh level and the 22-gauge/8cm needle is introduced in plain through the sartorius muscle. the correct position for the tip of the needle in the adductor canal is checked and a bolus injection of 0.5% ropivacaine 15ml is given.

test group
control groupPROCEDURE

After the end of the surgery, at the arrival of PACU, the patient's leg is prepared and draped in a sterile manner. Assisted by the high-frequency linear ultrasound transducer, we target the mid-thigh level and the 22-gauge/8cm needle is introduced in plain through the sartorius muscle. the correct position for the tip of the needle in the adductor canal is checked and a bolus injection of normal saline15ml is given.

control group

Eligibility Criteria

Age19 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult patients receiving total-knee arthroplasty under spinal anesthesia
  • ASA class 1-3

You may not qualify if:

  • infection at the needle injection site
  • hard for pain evaluation
  • CRPS patient with lower extremity symptom
  • chronic opioid user
  • those with side effect to local anesthetics
  • those getting revision total-knee arthroplasty or with the previous operation at the same knee area
  • those getting the surgery under general anesthesia due to the failed spinal anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 110-744, South Korea

Location

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

May 19, 2020

First Posted

May 22, 2020

Study Start

May 28, 2020

Primary Completion

June 22, 2021

Study Completion

June 29, 2021

Last Updated

November 24, 2023

Record last verified: 2023-11

Locations